Bayesian Capital Management, LP - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$243,360
+98.6%
31,200
+84.6%
0.03%
+86.7%
Q1 2023$122,525
-40.2%
16,900
-26.8%
0.02%
-50.0%
Q4 2022$204,897
-42.0%
23,100
-19.8%
0.03%
-58.3%
Q3 2022$353,000
+30.3%
28,800
+25.8%
0.07%
+44.0%
Q2 2022$271,000
-21.4%
22,900
+172.6%
0.05%
-50.0%
Q3 2021$345,0008,4020.10%
Other shareholders
EDITAS MEDICINE INC shareholders Q3 2021
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders